Yatin M. Vyas, MD named chair of pediatric hematology oncology
Monday, June 24, 2013
Yatin M. Vyas, MD has been named chair of the Division of Pediatric Hematology Oncology. Vyas will assume the role effective July 1, 2013.
Vyas received his primary medical degree from Asia's largest academic medical center in India. He later came to the United States in 1993 to pursue his pediatric residency training at the New York University Medical Center. Thereafter, he completed a highly-competitive pediatric hematology-oncology clinical fellowship program at Memorials Sloan-Kettering Cancer Center and Cornell University in New York. Vyas has also served as a faculty member at Memorial Sloan-Kettering Cancer Center within the pediatric sarcoma program.
Vyas was most recently on the faculty of the University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh. He is an NIH-funded investigator who is internationally recognized for his studies on Wiskott-Aldrich syndrome. Vyas' research program focuses on determining the partners and pathways of WAS protein participation in transcriptional regulation of immune function genes. Recently, the Vyas group has identified a novel function for WAS protein in the transcriptional regulation of t-helper cell (Th) differentiation through its effect on epigenetic modifications at the gene-promoter locus of Th1-specific genes.
Yatin Vyas is a recipient of the faculty award from the American Society of Hematology, a merit award from the 13th International Histocompatibility Workshop and Congress, an award from the United States Immune Deficiency Network, as well an an elected member of the Society for Pediatric Research.